Skip to main content
SpringerLink
Log in

Functional Symptoms in Pediatric Dermatology: The Canary in the Coal Mine

  • Chapter
  • First Online:
Functional Symptoms in Pediatric Disease

  • 1549 Accesses

Abstract

The skin is a window into the state of health revealing genetic predispositions, hormonal balance, nutritional status, and internal wellness. It exposes stress burden, emotional well-being, and psychological health. In this way the skin can operate as the metaphorical canary in the coal mine announcing the body’s hidden alarm signals. Psychocutaneous disorders draw attention to the intimate connections between the mind and the skin. During development, the brain and skin are born from the same embryonic tissue and throughout life they continue to be connected through elegant interactions involving neuropeptides, hormones, and inflammatory mediators, the so-called molecules of emotion. Disfiguring skin disease such as vitiligo, acne vulgaris, and ichthyosis have large emotional and psychological interactions. Perhaps surprisingly, the extent of the psychological fallout that results from these conditions is not necessarily related to the objective nature of the disease. Instead it is highly correlated with its subjective severity, which is dependent on self-perception and is highly personal. Recurrent skin disease often results in anxiety, depression, social isolation, body dysmorphic disorder, and dramatic reductions in quality of life rivaling those associated with debilitating systemic illnesses. Crosstalk between the mind and skin also exists wherein physical or psychological stressors can both initiate and worsen skin disease that has clear organic underpinnings such as acne vulgaris, psoriasis, atopic dermatitis, alopecia areata, and cutaneous warts. Primary psychiatric disorders may result in skin and hair conditions such as trichotillomania, psychogenic excoriation, dermatitis artefacta, and delusions of parasitosis. Although mind–skin interactions can cause obstinate symptoms and skin disease, these same connections can also be harnessed for therapeutic benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gupta MA. Somatization disorders in dermatology. Int Rev Psychiatry. 2006;18(1):41–7.

    PubMed  Google Scholar 

  2. Klokk M, Gotestam KG, Mykletun A. Factors accounting for the association between anxiety and depression, and eczema: the Hordaland health study (HUSK). BMC Dermatol. 2010;10:3.

    PubMed Central  PubMed  Google Scholar 

  3. Ahmar H, Kurban AK. Psychological profile of patients with atopic dermatitis. Br J Dermatol. 1976;95(4):373–7.

    PubMed  CAS  Google Scholar 

  4. Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun. 1997;11(4):286–306.

    PubMed  CAS  Google Scholar 

  5. Dhabhar FS, McEwen BS. Bi-directional effects of stress on immune function: possible explanations for salubrious as well as harmful effects. In: Ader R, editor. Psychoneuroimmunology. 4th ed. San Diego, CA: Elsevier Academic; 2007. p. 723–60.

    Google Scholar 

  6. Dhabhar FS. Effects of psychological stress on skin immune function: implications for immunoprotection versus immunopathology. In: Granstein RD, Luger T, editors. Neuroimmunology of the skin: basic science to clinical practice. Berlin: Springer; 2010. p. 113–23.

    Google Scholar 

  7. Ader R, editor. Psychoneuroimmunology. 4th ed. San Diego, CA: Elsevier Academic; 2007.

    Google Scholar 

  8. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5(3):243–51.

    PubMed  CAS  Google Scholar 

  9. Grossbart TA, Sherman C. Skin deep: a mind/body program for healthy skin. 2nd ed. Santa Fe: Health Press; 1992.

    Google Scholar 

  10. Griesemer RD. Emotionally triggered disease in a dermatologic practice. Psychiatr Ann. 1978;8(8):49–56.

    Google Scholar 

  11. Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom. 2001;70(1):6–16.

    PubMed  CAS  Google Scholar 

  12. Colavincenz ML, Granstein RD. Stress and the skin: a meeting report of the Weill Cornell Symposium on the science of dermatology. J Invest Dermatol. 2006;126(12):2560–1.

    Google Scholar 

  13. Weston WL, Huff JC. Atopic dermatitis: etiology and pathogenesis. Pediatr Ann. 1976;5(12):759–62.

    PubMed  CAS  Google Scholar 

  14. Koo J, Lebwohl A. Psycho dermatology: the mind and skin connection. Am Fam Physician. 2001;64(11):1873–8.

    PubMed  CAS  Google Scholar 

  15. Hall JM, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME. Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract. 2012;2012:403908.

    PubMed Central  PubMed  Google Scholar 

  16. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351(9111):1225–32.

    Google Scholar 

  17. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314–24.

    PubMed  CAS  Google Scholar 

  18. Koblenzer PJ. Parental issues in the treatment of chronic infantile eczema. Dermatol Clin. 1996;14(3):423–7.

    PubMed  CAS  Google Scholar 

  19. Panconesi E, Hautmann G. Psychophysiology of stress in dermatology. The psychobiologic pattern of psychosomatics. Dermatol Clin. 1996;14(3):399–421.

    PubMed  CAS  Google Scholar 

  20. Nadelson T. A person’s boundaries: a meaning of skin disease. Cutis. 1978;21(1):90–3.

    PubMed  CAS  Google Scholar 

  21. Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol. 2000;142(2):288–97.

    PubMed  CAS  Google Scholar 

  22. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child. 1997;76(2):159–62.

    PubMed Central  PubMed  CAS  Google Scholar 

  23. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145–51.

    PubMed  CAS  Google Scholar 

  24. Lewis-Jones MS, Finlay AY. The children’s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–9.

    PubMed  CAS  Google Scholar 

  25. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol. 1998;138(1):107–13.

    PubMed  CAS  Google Scholar 

  26. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, Sampson HA, Lupo M. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med. 1995;149(8):856–60.

    PubMed  CAS  Google Scholar 

  27. Camfferman D, Kennedy JD, Gold M, Martin AJ, Lushington K. Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev. 2010;14(6):359–69.

    PubMed  Google Scholar 

  28. Meltzer LJ, Moore M. Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. J Pediatr Psychol. 2008;33(3):279–91.

    PubMed  Google Scholar 

  29. Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol. 2006;154(3):514–8.

    PubMed  CAS  Google Scholar 

  30. Garrie SA, Garrie EV. Anxiety and skin diseases. Cutis. 1978;22(2):205–8.

    PubMed  CAS  Google Scholar 

  31. Kuruvila M, Gahalaut P, Zacharia A. A study of skin disorders in patients with primary psychiatric conditions. Indian J Dermatol Venereol Leprol. 2004;70(5):292–5.

    PubMed  Google Scholar 

  32. Hashizume H, Takigawa M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2006;6(5):335–9.

    PubMed  CAS  Google Scholar 

  33. Koblenzer CS, Koblenzer PJ. Chronic intractable atopic eczema. Its occurrence as a physical sign of impaired parent-child relationships and psychologic developmental arrest: improvement through parent insight and education. Arch Dermatol. 1988;124(11):1673–7.

    PubMed  CAS  Google Scholar 

  34. Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S, Ichihashi M. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol. 1999;104(1):173–6.

    PubMed  CAS  Google Scholar 

  35. Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci. 1997;14(1):63–7.

    PubMed  CAS  Google Scholar 

  36. Buske-Kirschbaum A, Jobst S, Wustmans A, Kirshbaum C, Rauh W, Hellhammer D. Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom Med. 1997;59(4):419–26.

    PubMed  CAS  Google Scholar 

  37. Absolon CM, Cottrell D, Eldridge SM, Glover MT. Psychological disturbance in atopic eczema: the extent of the problem in school-aged children. Br J Dermatol. 1997;137(2):241–5.

    PubMed  CAS  Google Scholar 

  38. Dennis H, Rostill H, Reed J, Gill S. Factors promoting psychological adjustment to childhood atopic eczema. J Child Health Care. 2006;10(2):126–39.

    PubMed  Google Scholar 

  39. Kilpeläinen M, Koskenvuo M, Hellenius H, Terho EO. Stressful life events promote the manifestation of asthma and atopic diseases. Clin Exp Allergy. 2002;32(2):256–63.

    PubMed  Google Scholar 

  40. Bockelbrink A, Heinrich J, Schäfer I, Zutavern A, Borte M, Herbarth O, Schaaf B, von Berg A, Schäfer T, LISA Study Group. Atopic eczema in children: another harmful sequel of divorce. Allergy. 2006;61(12):1397–402.

    PubMed  CAS  Google Scholar 

  41. Grant JE, Odlaug BL, Potenza MN. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007;15(2):80–5.

    PubMed  Google Scholar 

  42. Harth W, Gieler U, Kusnir D, Tausk FA, editors. Clinical Management in Psychodermatology. Berlin: Springer; 2010.

    Google Scholar 

  43. Tay YK, Levy ML, Metry DW. Trichotillomania in childhood: case series and review. Pediatrics. 2004;113(5):e494–8.

    PubMed  Google Scholar 

  44. Azrin NH, Nunn RG. Habit control in a day. New York, NY: Simon & Schuster; 1977.

    Google Scholar 

  45. Christenson GA, Pyle RL, Mitchell JE. Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry. 1991;52(10):415–7.

    PubMed  CAS  Google Scholar 

  46. King RA, Scahill L, Vitulano LA, Schwab-Stone M, Tercyak Jr KP, Riddle MA. Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. J Am Acad Child Adolesc Psychiatry. 1995;34(11):1451–9.

    PubMed  CAS  Google Scholar 

  47. Christenson G. Trichotillomania from prevalence to comorbidity. Psychiatr Times. 1995;12(9):44–8.

    Google Scholar 

  48. Flessner CA, Woods DW, Franklin ME, Keuthen NJ, Piacentini J. Trichotillomania Learning Center-Scientific Advisory Board TLC-SAB. Styles of pulling in youths with trichotillomania: exploring differences in symptom severity, phenomenology, and comorbid psychiatric symptoms. Behav Res Ther. 2008;46(9):1055–61.

    PubMed  Google Scholar 

  49. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004;123(3):455–7.

    PubMed  CAS  Google Scholar 

  50. Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med. 1989;321(8):497–501.

    PubMed  CAS  Google Scholar 

  51. Stein DJ, Bouwer C, Maud CM. Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania. Eur Arch Psychiatry Clin Neurosci. 1997;247(4):234–6.

    PubMed  CAS  Google Scholar 

  52. Lewin AB, Piacentini J, Flessner CA, Woods DW, Franklin ME, Keuthen NJ, Moore P, Khanna M, March JS, Stein DJ, TLC-SAB. Depression, anxiety, and functional impairment in children with trichotillomania. Depress Anxiety. 2009;26(6):521–7.

    PubMed  Google Scholar 

  53. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry. 1996;57 Suppl 8:42–7. discussion 48–9.

    PubMed  Google Scholar 

  54. Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King Jr LE, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D. National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004;51(3):440–7.

    PubMed  Google Scholar 

  55. Swedo SE, Leonard HL. Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr Clin North Am. 1992;15(4):777–90.

    PubMed  CAS  Google Scholar 

  56. Balkrishnan R, Kulkarni AS, Cayce K, Feldman SR. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis. 2006;77(4):251–5.

    PubMed  Google Scholar 

  57. Tidman MJ. Prompt treatment of acne improves quality of life. Practitioner. 2012;256(1752):15–7. 2.

    PubMed  Google Scholar 

  58. Szabó K, Kemény L. Studying the genetic predisposing factors in the pathogenesis of acne vulgaris. Hum Immunol. 2011;72(9):766–73.

    PubMed  Google Scholar 

  59. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem. 2011;44(13):1035–40.

    PubMed  CAS  Google Scholar 

  60. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA. 2002;99(10):7148–53.

    PubMed Central  PubMed  CAS  Google Scholar 

  61. Paoli A, Grimaldi K, Toniolo L, Canato M, Bianco A, Fratter A. Nutrition and acne: therapeutic potential of ketogenic diets. Skin Pharmacol Physiol. 2012;25(3):111–7.

    PubMed  CAS  Google Scholar 

  62. Veith WB, Silverberg NB. The association of acne vulgaris with diet. Cutis. 2011;88(2):84–91.

    PubMed  Google Scholar 

  63. Yosipovitch G, Tang M, Dawn AG, Chen M, Goh CL, Huak Y, Seng LF. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol. 2007;87(2):135–9.

    PubMed  Google Scholar 

  64. Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol. 2003;139(7):897–900.

    PubMed  Google Scholar 

  65. Koo JY, Smith LL. Psychologic aspects of acne. Pediatr Dermatol. 1991;8(3):185–8.

    PubMed  CAS  Google Scholar 

  66. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4(12):833–42.

    PubMed  Google Scholar 

  67. Zouboulis CC, Böhm M. Neuroendocrine regulation of sebocytes—a pathogenetic link between stress and acne. Exp Dermatol. 2004;13 Suppl 4:31–5.

    PubMed  CAS  Google Scholar 

  68. Sulzberger MB, Zaidens SH. Psychogenic factors in dermatologic disorders. Med Clin North Am. 1948;32:669–85.

    PubMed  CAS  Google Scholar 

  69. Shalita A. Treatment of refractory acne. Dermatology. 1980;3:23–4.

    Google Scholar 

  70. Lorenz TH, Graham DT, Wolf S. The relation of life stress and emotions to human sebum secretion and to the mechanism of acne vulgaris. J Lab Clin Med. 1953;41(1):11–28.

    PubMed  CAS  Google Scholar 

  71. Hughes H, Brown BW, Lawlis GF, Fulton Jr JE. Treatment of acne vulgaris by biofeedback relaxation and cognitive imagery. J Psychosom Res. 1983;27(3):185–91.

    PubMed  CAS  Google Scholar 

  72. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21(5):457–87.

    PubMed  CAS  Google Scholar 

  73. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80(3):979–1020.

    PubMed  CAS  Google Scholar 

  74. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R. Cutaneous expression of CRH and CRH-R. Is there a “skin stress response system?”. Ann N Y Acad Sci. 1999;885:287–311.

    PubMed  CAS  Google Scholar 

  75. Stokes JH, Pillsbury DH. The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Arch Dermatol Syphilol. 1930;22:962–93.

    Google Scholar 

  76. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis—back to the future? Gut Pathog. 2011;3(1):1.

    PubMed Central  PubMed  Google Scholar 

  77. Uslu G, Sendur N, Uslu M, Savk E, Karaman G, Eskin M. Acne: prevalence, perceptions and effects on psychological health among adolescents in Aydin, Turkey. J Eur Acad Dermatol Venereol. 2008;22(4):462–9.

    PubMed  CAS  Google Scholar 

  78. Ayer J, Burrows N. Acne: more than skin deep. Postgrad Med J. 2006;82(970):500–6.

    PubMed Central  PubMed  CAS  Google Scholar 

  79. Fried RG, Gupta MA, Gupta AK. Depression and skin disease. Dermatol Clin. 2005;23(4):657–64.

    PubMed  CAS  Google Scholar 

  80. Fried RG, Wechsler A. Psychological problems in the acne patient. Dermatol Ther. 2006;19(4):237–40.

    PubMed  Google Scholar 

  81. Purvis D, Robinson E, Merry S, Watson P. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediatr Child Health. 2006;42(12):793–6.

    PubMed  Google Scholar 

  82. Halvorsen JA, Stern RS, Dalgard F, Thorsen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131(2):363–70.

    PubMed  CAS  Google Scholar 

  83. Hahm BJ, Min SU, Yoon MY, Shin YW, Kim JS, Jung JY, Suh DH. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. J Dermatol. 2009;36(5):255–61.

    PubMed  CAS  Google Scholar 

  84. Pawin H, Chivot M, Beylot C, Faure M, Poli F, Revuz J, Dréno B. Living with acne. A study of adolescents’ personal experiences. Dermatology. 2007;215(4):308–14.

    PubMed  Google Scholar 

  85. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–6.

    PubMed  CAS  Google Scholar 

  86. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol. 1988;18(2 Pt 1):325–33.

    PubMed  CAS  Google Scholar 

  87. van der Meeren HL, van der Schaar WW, van den Hurk CM. The psychological impact of severe acne. Cutis. 1985;36(1):84–6.

    PubMed  Google Scholar 

  88. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol. 1987;17(1):25–32.

    PubMed  CAS  Google Scholar 

  89. Gupta MA, Gupta AK, Schork NJ, Ellis CN, Voorhees JJ. Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations. Int J Dermatol. 1990;29(10):719–21.

    PubMed  CAS  Google Scholar 

  90. Dunn LK, O’Neill JL, Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011;17(1):1.

    PubMed  Google Scholar 

  91. Rapp DA, Brenes GA, Feldman SR, Fleischer Jr AB, Graham GF, Dailey M, Rapp SR. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004;151(1):183–9.

    PubMed  CAS  Google Scholar 

  92. Bowe WP, Leyden JJ, Crerand CE, Sarwer DB, Margolis DJ. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol. 2007;57(2):222–30.

    PubMed  Google Scholar 

  93. Jafferany M, Vander Stoep A, Dumitrescu A, Hornung RL. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Int J Dermatol. 2010;49(7):784–9.

    PubMed  Google Scholar 

  94. Richards HL, Fortune DG, Weidmann A, Sweeney SK, Griffiths CE. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol. 2004;151(6):1227–33.

    PubMed  CAS  Google Scholar 

  95. Jafferany M, et al. Psychocutaneous disorders: a survey study of psychiatrists’ awareness and treatment patterns. South Med J. 2010;103(12):1199–203.

    PubMed  Google Scholar 

  96. Merz B. Hypnosis for burn patients: healing body and spirit. JAMA. 1983;249(3):321–3.

    PubMed  CAS  Google Scholar 

  97. Shakibaei F, Harandi AA, Gholamrezaei A, Samoei R, Salehi P. Hypnotherapy in management of pain and reexperiencing of trauma in burn patients. Int J Clin Exp Hypn. 2008;56(2):185–97.

    PubMed  Google Scholar 

  98. Patterson DR, Everett JJ, Burns GL, Marvin JA. Hypnosis for the treatment of burn pain. J Consult Clin Psychol. 1992;60(5):713–7.

    PubMed  CAS  Google Scholar 

  99. Patterson DR, Goldberg ML, Ehde DM. Hypnosis in the treatment of patients with severe burns. Am J Clin Hypn. 1996;38(3):200–12. discussion 213.

    PubMed  CAS  Google Scholar 

  100. Shenefelt PD. Complementary psychocutaneous therapies in dermatology. Dermatol Clin. 2005;23(4):723–34.

    PubMed  CAS  Google Scholar 

  101. Twerski AJ, Naar R. Hypnotherapy in a case of refractory dermatitis. Am J Clin Hypn. 1974;16(3):202–5.

    PubMed  CAS  Google Scholar 

  102. Stewart AC, Thomas SE. Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol. 1995;132(5):778–83.

    PubMed  CAS  Google Scholar 

  103. Lee KC, Keyes A, Hensley JR, Gordon JR, Kwasny MJ, West DP, Lio PA. Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial. Acupunct Med. 2012;30(1):8–11.

    PubMed  Google Scholar 

  104. Spanos NP, Williams V, Gwynn MI. Effects of hypnotic, placebo, and salicylic acid treatments on wart regression. Psychosom Med. 1990;52(1):109–14.

    PubMed  CAS  Google Scholar 

  105. Ewin DM. Hypnotherapy for warts (verruca vulgaris): 41 consecutive cases with 33 cures. Am J Clin Hypn. 1992;35(1):1–10.

    PubMed  CAS  Google Scholar 

  106. Ewin DM. Treatment of HPV with hypnosis–psychodynamic considerations of psychoneuroimmunology: a brief communication. Int J Clin Exp Hypn. 2011;59(4):392–8.

    PubMed  Google Scholar 

  107. Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wenger R, Nudel J, Pittenger C, Leckman JF, Coric V. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry. 2007;62(8):839–46.

    PubMed  CAS  Google Scholar 

  108. Van Ameringen M. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2010;71(10):1336–43.

    PubMed  Google Scholar 

  109. Franklin ME, Zagrabbe K, Benavides KL. Trichotillomania and its treatment: a review and recommendations. Expert Rev Neurother. 2011;11(8):1165–74.

    PubMed Central  PubMed  Google Scholar 

  110. Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol. 2011;165(2):233–46.

    PubMed  CAS  Google Scholar 

  111. Smolinski KN, Yan AC. How and when to treat molluscum contagiosum and warts in children. Pediatr Ann. 2005;34(3):211–21.

    PubMed  Google Scholar 

  112. Kao M, Huang CM. Acne vaccines targeting Propionibacterium acnes. G Ital Dermatol Venereol. 2009;144(6):639–43.

    PubMed  CAS  Google Scholar 

  113. Nakatsuji T, Liu YT, Huang CP, Zouboulis CC, Gallo RL, Huang CM. Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS One. 2008;3(2):e1551.

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, 1600 NW 10th Ave RMSB 2023A, Miami, FL, 33136, USA

    Anna J. Nichols MD, PhD

  2. Department of Psychiatry/Psychology, Harvard Medical School, Marblehead, MA, USA

    Ted A. Grossbart PhD

Authors
  1. Anna J. Nichols MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ted A. Grossbart PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna J. Nichols MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA

    Ran D. Anbar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nichols, A.J., Grossbart, T.A. (2014). Functional Symptoms in Pediatric Dermatology: The Canary in the Coal Mine. In: Anbar, R. (eds) Functional Symptoms in Pediatric Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4899-8074-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-8074-8_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4899-8073-1

  • Online ISBN: 978-1-4899-8074-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation